Progress on the Study of PD-L1 Detection Methods in Non-small Cell Lung Cancer
PD-1/PD-L1 inhibitors play an important role in the first-line and second-line treatment of non-small cell lung cancer (NSCLC), indicating a new treatment strategy of NSCLC. Completed clinical trials have shown that effective detection of PD-L1 expression is the key to the use of immunosuppressive a...
Main Authors: | Xuejing GUO, He CAO, Jianya ZHOU, Jianying ZHOU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-01-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.01.08 |
Similar Items
-
Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer
by: Lihong Zhang, et al. -
Overexpression of IL-8 and MMP-9 Confer High Malignant Phenotype in Patients with Non-small Cell Lung Cancer
by: Zhidong LIU, et al.
Published: (2010-08-01) -
Detection of Chemerin and It’s Clinical Significance in Peripheral Blood of Patients with Lung Cancer
by: Xiaohan QU, et al.
Published: (2009-11-01) -
Expression levels of sPD-L1 and VEGF in serum of patients with acute myeloid leukemia
by: Chun Zhang, et al.
Published: (2018-04-01) -
Oral Fluid Antibody Detection in the Diagnosis of Gastric Helicobacter pylori Infection
by: Behzad Hooshm, et al.
Published: (2004-09-01)